FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and relates to a method for preparing a solution of human albumin comprising the step of reducing the level of dissolved oxygen in said albumin solution, the oxygen level is reduced to a concentration equal to or less than 0.5 ppm. Group of inventions also relates to a composition of human albumin, where albumin is prepared by this method.
EFFECT: group of inventions provides a solution of human albumin with an oxidation/reduction state similar to the oxidation/reduction state of albumin present in human blood plasma.
13 cl, 5 ex, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IN VITRO DIAGNOSING OF ALZHEIMER'S DISEASE ON BASIS OF ALBUMIN REDOX-STATUS IN CEREBROSPINAL FLUID | 2017 |
|
RU2696485C2 |
METHOD OF OBTAINING HIGHLY EFFICIENT HUMAN ALBUMIN FOR APPLICATION IN DETOXICATION THERAPY | 2008 |
|
RU2424822C2 |
METHOD OF COMMERCIAL-SCALE PURIFICATION OF HEMOGLOBIN | 1994 |
|
RU2145873C1 |
VIRUSES INACTIVATION OF WITH APPLICATION OF CAPRYLATE | 2013 |
|
RU2633059C2 |
PLASMA BLOOD ALBUMIN FRACTION DEPLETED WITH PREKALLIKREIN | 2003 |
|
RU2321421C2 |
COMPOSITIONS OF TETRAHYDROBIOPTERINE AND METHODS OF ITS QUANTITATIVE ASSESSMENT | 2008 |
|
RU2486899C2 |
METHOD FOR MAKING SEMI-PRODUCTS OF IMMUNOGLOBULIN AND ALBUMIN BIOPREPARATIONS OF SLAUGHTERED ANIMAL BLOOD, ABORTION AND PLACENTAL HUMAN BLOOD | 2016 |
|
RU2703537C2 |
METHOD OF PREPARING MONOMERIC ALBUMIN | 1997 |
|
RU2125888C1 |
METHOD OF TREATING OR PREVENTING DISEASE ASSOCIATED WITH DEPOSIT OF AMYLOID PROTEINS (VERSIONS) | 2010 |
|
RU2533806C2 |
METHOD FOR FINAL INACTIVATION OF PATHOGENIC MICROORGANISMS | 2013 |
|
RU2629866C1 |
Authors
Dates
2018-06-14—Published
2015-05-18—Filed